Vanguard Group Inc A Ikido Pharma Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AIKI
# of Institutions
14Shares Held
461KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Geode Capital Management, LLC Boston, MA46.1KShares$175,2210.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny45.9KShares$174,5180.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX39.8KShares$151,3650.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX20.5KShares$77,9000.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...